[Treatment of hypertensive insulin-resistant patients is a difficult decision to make. Metabolically neutral drugs should be the choice of treatment].
Lithell
H
H
institutionen för folkhälso- och vårdvetenskap, enheten för geriatrik, Uppsala universitet.
Berglund
L
L
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003657:Decision Making; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007333:Insulin Resistance; D008875:Middle Aged; D012307:Risk Factors; D012537:Scandinavian and Nordic Countries
D000959:Antihypertensive Agents